RPL22 and cancer: In addition, mutations in the ribosomal protein genes have been found to be involved in cancers such as endometrial cancer (RPL22), chronic lymphoblastic leukemia (RPS15), colorectal cancer (RPS20), and glioma (RPL5) [54].